Works matching IS 2160763X AND DT 2021 AND VI 10 AND IP 2


Results: 11
    1
    2
    3
    4
    5
    6
    7
    8
    9

    First‐in‐Human Studies of MW01‐6‐189WH, a Brain‐Penetrant, Antineuroinflammatory Small‐Molecule Drug Candidate: Phase 1 Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Studies in Healthy Adult Volunteers.

    Published in:
    Clinical Pharmacology in Drug Development, 2021, v. 10, n. 2, p. 131, doi. 10.1002/cpdd.795
    By:
    • Van Eldik, Linda J.;
    • Sawaki, Lumy;
    • Bowen, Karen;
    • Laskowitz, Daniel T.;
    • Noveck, Robert J.;
    • Hauser, Byron;
    • Jordan, Lynn;
    • Spears, Tracy G.;
    • Wu, Huali;
    • Watt, Kevin;
    • Raja, Shruti;
    • Roy, Saktimayee M.;
    • Watterson, D. Martin;
    • Guptill, Jeffrey T.
    Publication type:
    Article
    10
    11

    Issue Information.

    Published in:
    Clinical Pharmacology in Drug Development, 2021, v. 10, n. 2, p. 111, doi. 10.1002/cpdd.709
    Publication type:
    Article